We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$172M
AUM Growth
+$31.4M
Cap. Flow
+$6.81M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.07%
Holding
144
New
12
Increased
10
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.52M
2
NKE icon
Nike
NKE
+$1.55M
3
IRM icon
Iron Mountain
IRM
+$1.14M
4
AMZN icon
Amazon
AMZN
+$725K
5
ABBV icon
AbbVie
ABBV
+$337K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.61M
2
AGO icon
Assured Guaranty
AGO
+$1.43M
3
CLF icon
Cleveland-Cliffs
CLF
+$199K
4
AYTU icon
AYTU BioPharma
AYTU
+$199K
5
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$166K

Sector Composition

Rank Sector Weight
1 Healthcare 21.93%
2 Technology 18.94%
3 Industrials 10.96%
4 Financials 10.71%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMS icon
51
Fresenius Medical Care
FMS
$13B
$1.01M 0.58%
23,288
– –
AEP icon
52
American Electric Power
AEP
$71.9B
$971K 0.56%
12,193
– –
XLK icon
53
State Street Technology Select Sector SPDR ETF
XLK
$114B
$930K 0.54%
17,800
– –
LEVI icon
54
Levi Strauss
LEVI
$9.37B
$909K 0.53%
67,800
– –
MMP
55
DELISTED
Magellan Midstream Partners, L.P.
MMP
$879K 0.51%
20,350
+600
+3% +$25.3K
ELV icon
56
Elevance Health
ELV
$80.9B
$878K 0.51%
3,340
– –
DD icon
57
DuPont de Nemours
DD
$18.3B
$852K 0.49%
12,778
– –
SYF icon
58
Synchrony
SYF
$24.8B
$852K 0.49%
38,450
-400
-1% -$7.79K
TFC icon
59
Truist Financial
TFC
$65.4B
$849K 0.49%
22,600
-63
-0.3% -$2.27K
JPM icon
60
JPMorgan Chase
JPM
$907B
$838K 0.49%
8,910
+102
+1% +$9.68K
ETN icon
61
Eaton
ETN
$155B
$827K 0.48%
9,450
– –
NEE icon
62
NextEra Energy
NEE
$185B
$819K 0.48%
13,648
– –
GRA
63
DELISTED
W.R. Grace & Co.
GRA
$793K 0.46%
15,600
– –
CVX icon
64
Chevron
CVX
$373B
$765K 0.44%
8,570
-229
-3% -$20.5K
VZ icon
65
Verizon
VZ
$182B
$764K 0.44%
13,866
-626
-4% -$35.2K
BN icon
66
Brookfield
BN
$107B
$740K 0.43%
42,041
– –
WEC icon
67
WEC Energy
WEC
$36.9B
$719K 0.42%
8,200
– –
HZNP
68
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$709K 0.41%
12,750
– –
MDLZ icon
69
Mondelez International
MDLZ
$78.3B
$699K 0.41%
13,672
-295
-2% -$15.2K
NTRS icon
70
Northern Trust
NTRS
$34.2B
$674K 0.39%
8,500
– –
TAK icon
71
Takeda Pharmaceutical
TAK
$54.8B
$661K 0.38%
36,861
– –
DOW icon
72
Dow Inc
DOW
$21.6B
$652K 0.38%
15,984
– –
WFC.PRL icon
73
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.72B
$649K 0.38%
500
– –
MMM icon
74
3M
MMM
$83.4B
$568K 0.33%
4,357
– –
NTCT icon
75
NETSCOUT
NTCT
$2.95B
$568K 0.33%
22,240
-66
-0.3% -$1.71K
1 2
3
4 5

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Searle & Co held 144 positions worth $172M, up 22% from $141M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Searle & Co deployed $6.81M of net new capital in Q2 2020, opening 12 new positions and adding to 10 existing holdings. Its largest new stake was Nike: 16,795 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AYTU BioPharma, an estimated $199K trimmed.

  • Searle & Co's largest Q2 2020 buy was Nike: 16,795 shares worth $1.65M.
  • Searle & Co added most to Apple in Q2 2020, an estimated $4.52M increase.
  • Searle & Co's biggest Q2 2020 reduction was AYTU BioPharma, cutting an estimated $199K.
  • Searle & Co fully exited Allergan plc in Q2 2020, selling an estimated $1.61M.
  • Searle & Co's ten largest holdings make up 31% of its $172M portfolio in Q2 2020.
  • Searle & Co opened 12 new positions and closed 4 in Q2 2020.
  • Searle & Co's portfolio value rose 22% quarter-over-quarter to $172M.

Based on Searle & Co's 13F filing for Q2 2020, filed 3 Aug 2020.